Gufic Biosciences Company Description

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America.

The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals.

It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments.

In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products.

Further, it engages in contract and bulk drug manufacturing business. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.

Gufic Biosciences Limited

Country	India
Founded	1970
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,484
CEO	Pranav Choksi

Contact Details

Address: S.M. House Mumbai, Maharashtra 400057 India
Phone	91 22 6726 1000
Website	gufic.com

Stock Details

Ticker Symbol	GUFICBIO
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE742B01025
SIC Code	2834

Key Executives

Name	Position
Pranav Jayesh Choksi	Chief Executive Officer and Whole Time Director
Jayesh Pannalal Choksi	Chairman and MD
Pankaj Jayakumar Gandhi	Whole-Time Director
Devkinandan B. Roonghta	Chief Financial Officer
Nagesh Yarrabathina	Chief Operating Officer
Avik Das	Investor Relations Officer
Ami Naresh Shah	Senior Manager of Legal, Company Secretary and Compliance Officer
Pinak Padhya	Associate Vice President - Sales and Marketing
Sunil Desai	Head ? Human Resource Department
Ashok Laxman Dev	President of Operation